Clinical Trial Update: Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of selumetinib with irinotecan in previously treated colorectal cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Selumetinib (selumetinib)

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED